MACLOZYME Trademark

Trademark Overview

On Thursday, April 4, 2013, a trademark application was filed for MACLOZYME with the United States Patent and Trademark Office. The USPTO has given the MACLOZYME trademark a serial number of 85895736. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 28, 2016. This trademark is owned by Curemark, LLC. The MACLOZYME trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of pervasive development disorders and dysautonomia
maclozyme

General Information

Serial Number85895736
Word MarkMACLOZYME
Filing DateThursday, April 4, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 28, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2013

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of pervasive development disorders and dysautonomia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 11, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCuremark, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRye, NY 10580
Party NameCuremark, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRye, NY 10580

Trademark Events

Event DateEvent Description
Monday, November 28, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 28, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 2, 2016EXTENSION 5 GRANTED
Monday, April 4, 2016EXTENSION 5 FILED
Monday, April 4, 2016TEAS EXTENSION RECEIVED
Tuesday, September 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 21, 2015EXTENSION 4 GRANTED
Wednesday, September 16, 2015EXTENSION 4 FILED
Wednesday, September 16, 2015TEAS EXTENSION RECEIVED
Tuesday, April 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 6, 2015EXTENSION 3 GRANTED
Thursday, April 2, 2015EXTENSION 3 FILED
Thursday, April 2, 2015TEAS EXTENSION RECEIVED
Tuesday, November 18, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 17, 2014EXTENSION 2 GRANTED
Wednesday, October 22, 2014EXTENSION 2 FILED
Wednesday, November 12, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 22, 2014TEAS EXTENSION RECEIVED
Tuesday, April 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 4, 2014EXTENSION 1 GRANTED
Friday, April 4, 2014EXTENSION 1 FILED
Friday, April 4, 2014TEAS EXTENSION RECEIVED
Tuesday, October 22, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 27, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2013PUBLISHED FOR OPPOSITION
Wednesday, August 7, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 18, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 17, 2013ASSIGNED TO EXAMINER
Thursday, April 11, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 8, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

maclozyme disorders dysautonomia development pervasive preparations treatment pharmaceutical